Frontlight ResearchEarly access
Ovarian cancer trials in Spain
90 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Where
- Barcelona, Córdoba, Girona, L'Hospitalet de Llobregat, Madrid, Murcia, Pamplona, Valencia
- Age
- 18 years to 99 years
- People
- 160 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07023627 · EU 2025-521513-14-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Madrid, Málaga, Sabadell, Santiago de Compostela, Valencia
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - Phase 2/3Taking peopleRecurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
- Where
- Madrid, Murcia, Valencia
- Age
- 18 years and over
- People
- 138 worldwide
- Run by
- ARCAGY/ GINECO GROUP
See details and how to joinNCT03651206 - Phase 1Taking peopleStudy to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies
- Where
- Barcelona, Córdoba, Girona, L'Hospitalet de Llobregat, Logrono, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Sevilla, Valencia
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Duke Street Bio Ltd
See details and how to joinNCT06458712 · EU 2023-508805-26-00 - Phase 1Taking peopleA Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
- Where
- Barcelona, Madrid
- Age
- 18 years and over
- People
- 187 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07306559 · EU 2025-522913-45-00 - Phase 1/2Taking peopleA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Barcelona, Girona, Madrid, Majadahonda, Palma, Pamplona, Pozuelo de Alarcón, Sabadell, Salamanca, Santiago de Compostela, Sevilla, Valencia
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Badalona, Barcelona, Madrid, Málaga, Pamplona
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - Phase 1Taking peopleStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Madrid
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- MOMA Therapeutics
See details and how to joinNCT06545942 - Phase 3Taking peopleAZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Where
- A Coruña, Badalona, Barcelona, Córdoba, Donostia, Girona, L'Hospitalet de Llobregat, Madrid, Valencia
- Age
- 18 years and over
- People
- 1,100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00 - Phase 2Taking peopleTrial to Better Characterize the Status of HRD leading to a Benefit from Olaparib in Combination with Bevacizumab in Patients with Advanced Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer. STROBE
- Where
- Badalona, Barcelona, Córdoba, Girona, Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Madrid, Majadahonda, Palma, Sevilla, Valencia, Zaragoza
- Age
- 18 years and over
- People
- 100
- Run by
- Vall D Hebron Institute Of Oncology
See details and how to joinNCT06377267 · EU 2024-517363-24-00 - Phase 1Not yet taking people in SpainA Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
- Where
- Barcelona, Madrid, Pamplona
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06476808 · EU 2025-523067-38-01 - Phase 2Taking peopleRelacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- Where
- Badalona, Barcelona, Madrid, Valencia
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Corcept Therapeutics
See details and how to joinNCT06906341 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Reus, Sevilla
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Barcelona, Elche, Jerez de la Frontera, Madrid, Málaga, Santander
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - Phase 1Taking peopleA First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
- Where
- Barcelona, Logrono, Madrid, Majadahonda, Málaga, Pamplona, Pozuelo de Alarcón, Valencia
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Stemline Therapeutics, Inc.
See details and how to joinNCT07226427 · EU 2025-524168-39-00 - No phaseTaking peoplePROV-MESH: Prophylactic Ovarian Cancer MESH
- Where
- Barcelona
- Age
- 18 years and over
- People
- 152
- Run by
- Hospital Vall d'Hebron
See details and how to joinNCT07676370 - Phase 2Taking peopleA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Madrid
- Age
- 18 years and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - Phase 1Not yet taking people in SpainStudy of STP938 (Dencatistat) in Advanced Solid Tumours
- Where
- Barcelona, Madrid, Sevilla, Valencia
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- Step Pharma, SAS
See details and how to joinNCT06297525 · EU 2024-512375-12-00 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Where
- Badalona, Barcelona, Valencia
- Age
- 18 years and over
- People
- 182 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT04300556 · EU 2023-506868-14-00 - No phaseTaking peoplePerformance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
- Where
- Manresa
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Aesculap AG
See details and how to joinNCT06024109 - Phase 2Taking peopleA Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
- Where
- Badalona, Barcelona, El Palmar, Jaén, Madrid, Pamplona, Seville, Valencia, Zaragoza
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- AbbVie
See details and how to joinNCT06682988 · EU 2024-517184-23-00 - Phase 2Taking peopleA Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
- Where
- Barcelona, Madrid, Pamplona, Valencia
- Age
- 18 years and over
- People
- 114 worldwide
- Run by
- Oncoinvent Solutions AS
See details and how to joinNCT06504147 - Phase 2CompletedA basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
- Where
- Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
- Age
- 18 years and over
- People
- 101 worldwide
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780 · EU 2022-502654-14-00 - Phase 2Taking peopleNiraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
- Where
- A Coruña, Barakaldo, Barcelona, Girona, Jaén, Madrid, Málaga, Oviedo, Reus, Sevilla, Valencia
- Age
- 18 years and over
- People
- 30
- Run by
- MedSIR
See details and how to joinNCT06180356 · EU 2023-508258-24-00